Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Qingyu Luo, Ph.D.

Concepts (13)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Qingyu Luo's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Qingyu Luo has written about over time.
Animals, 1 publications between 2024 and 2024, average publication date May 2024. Cell Line, 1 publications between 2024 and 2024, average publication date May 2024. Class Ib Phosphatidylinositol 3-Kinase, 1 publications between 2024 and 2024, average publication date May 2024. Cytarabine, 1 publications between 2024 and 2024, average publication date May 2024. Humans, 1 publications between 2024 and 2024, average publication date May 2024. Leukemia, 1 publications between 2024 and 2024, average publication date May 2024. Mice, 1 publications between 2024 and 2024, average publication date May 2024. Mitochondria, 1 publications between 2024 and 2024, average publication date May 2024. Oxidative Phosphorylation, 1 publications between 2024 and 2024, average publication date May 2024. p21-Activated Kinases, 1 publications between 2024 and 2024, average publication date May 2024. Phosphorylation, 1 publications between 2024 and 2024, average publication date May 2024. Signal Transduction, 1 publications between 2024 and 2024, average publication date May 2024. Xenograft Model Antitumor Assays, 1 publications between 2024 and 2024, average publication date May 2024.

To see the data from this visualization as text, click here.
Luo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (13)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.